Drug Profile


Alternative Names: Aspirin/sumatriptan 325/12.5; VVD 101

Latest Information Update: 11 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Vivid Pharma Inc
  • Class Antimigraines; Indoles; Nonsteroidal anti-inflammatories; Salicylic acids; Small molecules; Sulfonamides; Tryptamines
  • Mechanism of Action Cyclooxygenase inhibitors; Serotonin 1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Suspended Headache

Most Recent Events

  • 11 Apr 2017 Suspended - Phase-II for Headache (delayed alcohol induced) in USA (PO)
  • 01 Jan 2016 Vivid Pharma completes a phase II trial in Headache (delayed alcohol indced) in USA (NCT02176655)
  • 01 Jul 2014 Phase-II clinical trials in Headache (delayed alcohol induced) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top